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1. Introduction  
Acinetobacter is a Gram-negative coccobacillus that is strictly aerobic, nonmotile, catalase 
positive and oxidase negative. It is ubiquitous in nature, being found in soil and water. 
Members of the genus Acinetobacter have now clearly emerged as opportunistic nosocomial 
pathogens (Forster et al., 1998). Bacteremia, pneumonia, meningitis, urinary tract and 
surgical wound infections are the most common infections caused by this organism 
(Cisneros et al., 2002; Dijkshoorn et al., 2007). The taxonomy of the genus Acinetobacter has 
undergone extensive revision during the last two decades, and at least 31 named and 
unnamed species have now been described (Dijkshoorn et al., 2007). Of these, Acinetobacter 
baumannii and the closely related unnamed genomic species 3 and 13 sensu Tjernberg and 
Ursing (13TU) species were the most clinically relevant. In recent years, multidrug-resistant 
(MDR) A. baumannii are increasingly held responsible for nosocomial infections and MDR A. 
baumannii clones are spreading into new geographic areas with increasing number of strains 
acquiring many resistance genes (Navon venezia et al., 2005). Unfortunately, newer 
extended-spectrum ǃ-lactamases and different carbapenemases are emerging fast, leading to 
pan-resistant strains of A. baumannii.  
A. baumannii appears to have the propensity for developing multiple antimicrobial 
resistances extremely rapidly. This bacterium has shown a remarkable tendency to develop 
resistance to virtually every antibiotic class (Henwood et al., 2002). The emergence and 
quick dissemination of multiple drug resistant (MDR) A. baumannii and its genetic potential 
to carry and transfer diverse antibiotic resistance determinants pose a major threat in 
hospitals world-wide. The complex interplay of MDR clones, its rapid spread, their 
persistence through biofilm formation, their regulation by quorum sensing (QS), transfer of 
resistance elements and other interactions are contributing to the increasing woes and 
creating additional difficulties in treating infections caused by these organisms. This review 
article mainly focus on antibiotic resistance in Acinetobacter, the current understanding of 
biofilm production and its correlation with antibiotic resistance as well the quorum sensing 
mechanisms in Acinetobacter species.  
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2. Antibiotic resistance in Acinetobacter spp.  
A. baumannii is considered the paradigm of multi-resistant bacteria as the organism has an 
ever-increasing list of resistance determinants that can rapidly nullify most of the therapeutic 
armamentarium. Both acquired and intrinsic resistance mechanisms can contribute this multi-
resistance. The ability to acquire such resistance for multiple drugs may be due to either the 
acquisition of genetic elements carrying multiple resistant determinants or mutations affecting 
the expression of porins and/or efflux pump(s), which can minimize the activity of unrelated 
antimicrobial agents (Vila, 2007). It is also indicated that the outer membrane of Acinetobacter 
spp. acts as a substantial barrier against the penetration of these antibiotics. The results of one 
of the earliest studies suggest that one of the causes for the high antibiotic resistance of 
Acinetobacter is attributable to the presence of a small number of small-sized porins (Sato et al., 
1991). Apart from this, it was also shown earlier that the amount of Acinetobacter porin was less 
than 5% of the Total outer membrane proteins (OMP), while that of E. coli it was reported to be 
about 60% (Rosenbusch, 1974) that contributes to reduced permeability. The most widespread 
ǃ-lactamases with carbapenemase activity in A. baumannii are carbapenem hydrolysing class D 
ǃ-lactamases mediated by OXA genes that are most specific for this species. In addition, 
metallo-ǃ-lactamases have now been reported worldwide that confer resistance to all ǃ-
lactams except aztreonam (Dijkshoorn et al., 2007). Resistance to aminoglycosides in A. 
baumannii is mediated principally by aminoglycoside-modifying enzymes (AME’s). Further, 
multidrug efflux pump such as AdeABC may have a role in aminoglycoside resistance 
(Wieczorek et al., 2008). Quinolone resistance is often caused by modifications in the structure 
of DNA gyrase secondary to mutations in the quinolone resistance determining regions of the 
gyrA and parC genes.  
The main underlying resistance mechanisms to multiple antibiotics in Acinetobacter sp. can 
be summarily outlined as follows (i) production of hydrolysing enzymes for e.g. ǃ-lactam 
hydrolysis by different kinds of ǃ-lactamases (Class A to D ǃ-lactamases), (ii) changes in 
penicillin-binding proteins (PBPs) that prevent action of ǃ-lactams, (iii) alterations in the 
structure and number of porin proteins that result in decreased permeability to antibiotics 
through the outer membrane of the bacterial cell and (iv) the activity of efflux pumps that 
further decrease the concentration of antibiotics within the bacterial cell. But, among these ǃ-
lactamases, OXA- and metallo-carbapenemases seem to be more significant with their 
increasing incidence when compared to other ǃ-lactamases (Livermore et al., 2006). 
2.1 Resistance to β-lactam antibiotics  
Resistance for ǃ-lactams in Acinetobacter is been associated with the production of ǃ-
lactamases.  
2.1.1 β-lactamases  
Resistance due to the expression of hydrolysing enzymes such as cephalophorinases and 
amber class A–D ǃ-lactamases remains as one of the extensively studied and skilful 
resistance mechanism among the species of Acinetobacter. These enzymes to some extent 
hydrolyze carbapenems along with other ǃ-lactams. The most common carbapenemases 
detected in A. baumannii were either Class B ǃ- lactamases such as metallo ǃ- lactamases 
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(MBL) or class D ǃ- lactamases (also referred as carbapenem hydrolyzing oxicillinases 
(CHDLs)) (Livermore, 2007). While class A carbapenemases have been frequently detected 
in bacteria belonging to Enterobacteraceae family, they were not usually found in Acinetobacter 
spp. However, A. baumannii producing extended-spectrum ǃ-lactamases (ESBLs) have been 
reported, though it is not a common phenomenon (Livermore & Woodford, 2006). As there 
are emerging reports of arrival of newer broad spectrum ǃ- lactamases such as New Delhi 
metallo-beta lactamase -1 (NDM-1) (Karthikeyan et al., 2010) among Gram-negative 
pathogens including Acinetobacter and their progressing hydrolysing abilities makes this 
group of Gram-negative bacterial pathogens as superbugs by assisting them to survive in 
extreme conditions. The genes that code for multiple resistances are reported to be plasmid 
as well as chromosomally encoded.  
2.1.2 A- Class  
A. baumannii, like Pseudomonas aeruginosa, produces a naturally occurring AmpC ǃ-
lactamase, together with a naturally occurring oxacillinase with carbapenemase properties. 
ESBLs are plasmid-mediated ǃ-lactamases of predominant class A. ESBLs are capable of 
efficiently hydrolyzing penicillin, cephalosporin, the oxyimino group containing 
cephalosporins (cefotaxime, ceftazidime) and monobactams (aztreonam). ǃ-lactamase 
inhibitors (clavulanic acid, sulbactam and tazobactam) generally inhibit ESBL producing 
strains. A wide range of class A ESBLs have been reported in Acinetobacter sp. such as TEM, 
SHV, CTX-M, GES, SCO, PER and VEB. However, these resistant determinants are not 
universally present in Acinetobacter, as there are only isolated reports of them. Some of the 
documented ESBLs world-wide are PER-1 from Turkey, Korea, Russia, Romania, Belgium 
and France; VEB-1 from France and Belgium; TEM-116 and SHV-12 from China and The 
Netherlands; CTX-M-2 from Korea; bla Shv-5 –EBSL, TEM -92 from Italy and VEB -1 from 
Northern France and Belgium (Naiemi et al., 2005; Nass et al., 2006, 2007; Endimiani et al., 
2007). Nevertheless, they were not as common as MBL and CHDL in Acinetobacter species. 
2.1.3 B- Class  
Carbapenemases are the most versatile of all ǃ-lactamases and many of them recognize 
almost all hydrolysable ǃ-lactams. The most common hydrolyzing enzyme carbapenemases 
found in A. baumannii belong to either the class B family of beta-lactamases such as MBLs 
(IMP/VIM) or the OXA class D family of serine ǃ-lactamases (Poirel, 2006). Class B ǃ-
lactamases are also referred as MBLs has the highest level of carbapenem-hydrolyzing 
activity among the three classes of carbapenemases. MBLs have been identified in many 
Gram-negative bacteria including Acinetobacter genomic species 13 TU and A. baumannii and 
are resistant to the commercially available ǃ-lactamase inhibitors but susceptible to 
inhibition by metal ion chelators. Potent class B metallo-carbapenemases of the IMP, VIM, 
SIM and NDM type have been found in A. baumannii.  
There are numerous existing reports on IMP type of MBL in Acinetobacter spp (Lee et al., 
2003; Livermore, 2007). In A. baumannii, six IMP variants belonging to three different 
phylogroups have been identified and reported namely IMP-1 in Italy, Japan and South 
Korea; IMP-2 in Italy and Japan; IMP-4 in Hong Kong; IMP-5 in Portugal; IMP-6 in Brazil 
and IMP-11 in Japan (Poirel and Nordmann, 2006). In addition, IMP-4 has been identified in 
clinical isolates of Acinetobacter junii in Australia (Peleg et al., 2006). On the contrary, there 
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are only few studies that have documented MBL VIM type in Acinetobacter. In fact more 
than 100 clinical isolates screened by our group showed non-existence of VIM in this part of 
world. Surprisingly, P. aeruginosa isolates collected from the same hospital in our region 
showed the presence of VIM type of MBL and there was no cross transmission observed 
(Unpublished data). VIM-2-producing Acinetobacter spp. have been isolated in the Far East 
(Lee, et al., 2003) and in Germany (Toleman, 2004), while the VIM-1 determinant has been 
reported only in Greece (Tsakris 2006). One study recently identified VIM-4, which is 
nothing but a point mutant of VIM-1 and that has been previously identified only in 
Enterobacteriaceae (Luzzaro et al., 2008) and Pseudomonas spp. (Pournaras et al., 2003). This 
report on MBL VIM-4 determinant in Acinetobacter spp., emphasizes the fact that CHDLs are 
not the solitary factor for emergence of resistance to carbapenems in this genus. 
Interestingly, blaVIM-4 was identified in a non-A. baumannii isolate, thereby indicating that 
clinically insignificant Gram-negative bacterial species may also be reservoirs for MBL-
encoding genes. It is also noteworthy that the occurrence of VIM-4 in Acinetobacter in a country 
that has reported VIM-4 in P. aeruginosa previously (Pournaras et al., 2003). Concurrently, it 
was also observed in Greece that blaVIM-1 which is widespread in P. aeruginosa had 
apparently crossed the species barrier to reach Acinetobacter spp. Such examples might be yet 
another example of resistance genes crossing genus barrier (Tsakris et al., 2006).  
A small number of reports are available on other MBL types such as SIM-1, NDM-1 
encountered in Acinetobacter spp (Lee et al., 2005, Karthikeyan et al., 2010). Recently, a novel 
acquired MBL gene namely blaSIM-1 was detected in clinical isolates of A. baumannii from 
Korea (Lee et al., 2005). This SIM-1 is encoded by a class 1 integron-borne gene cassette and 
is more closely related to IMP-type enzymes than to other MBLs. Very recently new ǃ–
lactamase such as NDM-1 has been reported in A. baumannii (Karthikeyan et al., 2010). 
Interestingly, in this report NDM-1–positive isolate was also positive for both OXA-23 and 
IMP. The blaNDM-1– positive strain was more resistant to antibiotics than the strains that 
were harbouring both OXA-23 and IMP. Fortunately, it was found that this blaNDM-1–
positive A. baumannii strain was susceptible to several fluoroquinolone antibiotics and to 
polymyxin B (Chen et al., 2011). 
2.1.4 D- Class  
The most common carbapenemases detected in Acinetobacter are CHDLs that are also 
referred as Class-D oxacillinases. Among the nine clusters of carbapenem hydrolysing 
oxacillinases, four have been identified to date in A. baumannii. These included members of 
OXA-23, -24, -51, and -58 families. In addition, recently a novel class D enzyme named OXA-
143 has been reported from Germany. OXA-58 oxacillinase was the first enzyme to be 
identified in an A. baumannii isolate in France and subsequently this has been reported 
among A. baumannii isolates in several countries (Coelo et al., 2006). Contrary to many 
workers, one investigation opined that the carriage of OXA-58 but not of OXA-51 ǃ-
lactamase gene correlates with carbapenem resistance in A. baumannii (Tsakris, 2007). In one 
of the studies, epidemiologically unrelated Acinetobacter isolates that were positive for the 
presence blaOXA-51- and blaOXA-58-like carbapenemase genes was also shown to carry the 
blaVIM-1 in a class 1 integron, which is of much concern (Tsakris, 2008).  
Recently, a new OXA class D ǃ–lactamase Oxa-97 has been reported in Tunisia which 
belongs to Oxa58-like (subgroup) in Africa (Poirel et al., 2008). In one instance, a novel Oxa-
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143- CHDL in A. baumannii (Higgins et al., 2009) which is not associated with insertion 
sequence (IS) elements or integron features has been reported, which is bracketed by 2 
replicase genes and its incorporation was shown to be by homologous recombination. Oxa-
143 is a class D carbapenemase is similar to OXA-66/OXA-51-like enzyme that contributes 
to imipenem resistance, which was first reported from Taiwan. Off late, OXA-72 oxacillinase 
has been also reported in several carbapenem resistant A. baumannii isolates in Taiwan (Lu 
et al., 2009).  
It has also been discovered that blaOXA-51-like genes may be associated with carbapenem 
resistance in isolates with an adjacent copy of insertion sequence (IS) ISAbA1 (Turton et al., 
2006). IS elements presumed to enhance ǃ-lactamase gene expression by providing 
additional promoters. Repeated observations such as ISAba1, ISAba2, ISAba3, ISAba4 IS 
elements being often found upstream of the different ǃ- lactamases genes in A. baumannii 
can be taken as evidence for such assumption (Chen et al., 2008; Poirel 2006a. 2006b & 2008). 
In addition, one recent work demonstrated that a plasmid-borne CHDL with appropriate 
upstream ISs was enough to confer a high level of carbapenem resistance in A. baumannii. 
Moreover, a blaOXA-58 gene with an upstream insertion of a truncated ISAba3 and IS1008 
was detected on a plasmid obtained from a clinical carbapenem resistant isolate in one of the 
studies (Chen et al., 2008). Acquisition of a plasmid-borne blaOXA-58 gene with an upstream 
IS1008 insertion is also shown to confer a high level of carbapenem resistance to A. 
baumannii (Chen et al., 2008). Therefore, as observed for the natural blaAmpC gene of A. 
baumannii, ISAba1 might provide promoter sequences that enhance expression of associated 
genes. These promoter sequences are probably extremely efficient in A. baumannii, so that 
insertion of ISAba1 upstream of blaOXA-51-like genes might represent a true mechanism of 
carbapenem resistance, or at least decreased susceptibility. Hence, it is sensible to believe 
that the association of blaOXA -51 like genes with IS elements may have a role in increasing 
carbapenem resistance. At least in one instance, it was conclusively shown that the reduced 
susceptibility to carbapenems was related to selection of the ISAba1-related overexpression 
of blaOXA-66 that belongs to blaOXA-51 subgroup (Figueiredo et al., 2009). 
2.2 Modifications in target proteins  
2.2.1 Penicillin binding protein  
Carbapenem resistance in A. baumannii may be because of penicillin binding proteins (PBP) 
or porin modifications. The penicillin-binding domains of PBPs are transpeptidases or 
carboxypeptidases involved in peptidoglycan metabolism. Reduced expression level of PBP 
was observed in multidrug resistant strains in order to resist the activity of antibiotics. Some 
of the strategies adopted by A. baumannii, which have been uncovered, are the acquisition of 
an additional low-affinity PBP, overexpression of an endogenous low-affinity PBP and 
alterations in endogenous PBPs by point mutations or homologous recombination.  
One recent study strongly indicated an association between down-regulation of PBPs 
and/or alteration in PBPs for ǃ-lactam resistance in A. baumannii (Vashist et al., 2011). In this 
study, it was shown that one of the PBP designated PBP-7/8 is critical for the survival of A. 
baumannii strain AB307–0294 in the rat soft tissue infection and pneumonia models. 
Furthermore, it was shown PBP-7/8 either directly or indirectly contributes to the resistance 
of this strain to complement-mediated bactericidal activity (Russo, 2009).  
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2.2.2 gyrA and parC  
Quinolone resistance is often caused by modifications in the structure of DNA gyrase 
secondary to mutations in the quinolone resistance determining regions (QRDR) of the gyrA 
and parC genes. DNA gyrase and DNA topoisomerase IV encoded by gyrA and parC genes 
respectively, are among the housekeeping genes involved in DNA replication and 
processing are the targets for ciprofloxacin and other fluoroquinones. A point mutation on 
the gyrA gene (Ser-83 to leu) was observed in MDR strains of A. baumannii which is 
consistent with fluoroquinolone resistant phenotype. Sequencing of the parC gene also 
indicated mutations in the parC gene that caused an amino acid change at either Ser-80 or 
Glu-84 (Deccache et al., 2011)  
2.3 Alternations in permeability  
2.3.1 Changes in OMPs & porins  
Reducing the transport of ǃ-lactam into the periplasmic space via changes in porins or 
OMPs reduces the access to PBPs. The outer membrane in MDR A. baumannii is less 
permeable to antimicrobial agents than that in other susceptible ones. Alternations in 
permeability characteristics disturbs the ǃ-lactam assimilation into the periplasmic space, 
resulting in the weak activity of antibiotics. Several porins, including the 33-kDa CarO 
protein, that constitute a pore channel for influx of carbapenems, might be involved in such 
resistance. Sometimes disruption of OMP genes by ISAba10 element may lead to the 
inactivation of the OMPs like CarO thereby reducing the extent of which the antibiotic 
enters the cell. When the chromosomal locus containing the carO gene was cloned from 
clinical isolates and characterised, it was shown that only a single copy of carO, present in a 
single transcriptional unit, was present in the A. baumannii genome. The carO gene encodes a 
polypeptide of 247 aminoacid residues, with a typical N-terminal signal sequence and a 
predicted trans-membrane ǃ-barrel topology (Siroy et al., 2006). Remarkably, many recent 
studies have revealed that disruption of the carO gene by the IS elements such as ISAba1, 
ISAba125, or ISAba825 results in loss of activity of CarO OMP leading to carbapenem 
resistance in A. baumannii (Mussi et al., 2005; Poirel et al., 2006). Many recent reports of 
outbreaks caused by carbapenem resistant phenotypes and their characterization having 
revealed the loss or reduction of porins such as OMPs of 22-29 kDa, 47, 44, and 37kDa and 
one of 31 to 36 kDa substantiates the findings of many previous investigations on OMPs. 
Additional gene expression studies, along with phenotypic characterization, of these 
membrane proteins will conclusively clarify the role of membrane permeability in ǃ-lactam 
resistance. 
2.4 Efflux pumps 
Efflux pumps are the ones among the well studied mechanisms of resistance in A. baumannii, 
by which the bacterial cells overcome the action of antibiotics by expelling them out. For 
example the 3.9-Mb genome of A. baumannii AYE is reported to harbour 46 open reading 
frames (ORFs) encoding putative efflux pumps of different families (Fournier et al., 2006). 
The over expression of efflux pump genes have been reported in the antibiotic resistant 
strains which provides the evidence for the role of efflux pumps in making the bacteria 
multi-drug resistant. To date, five classes of efflux pumps have been reported to be present 
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in A. baumannii such as ATP binding cassette (ABC), major facilitator superfamily (MFS), 
multidrug and toxic compound extrusion (MATE), resistance–nodulation–cell division 
(RND) and small multidrug resistance (SMR).  
The efflux systems in A. baumannii that are completely characterized functionally so far 
include AdeABC, AdeFGH and AdeIJK (RND type), AbeM (MATE type), and CraA (MFS 
type) (Peleg, 2008; Roca, 2009; Damier-Piolle, 2009). We have only partial knowledge on the 
functionality of ABC and SMR efflux pumps (Iacono et al., 2008; Srinivasan et al., 2009)  
2.4.1 RND type efflux pump 
The RND class efflux pumps that are commonly found in Gram-negative bacteria are 
usually tripartite in nature, i. e. they comprise of three protein components such as 
cytoplasmic, inter-membrane or membrane fusion protein (MFP) and peripalsmic or outer 
membrane protein which are encoded by three different genes present in a single operon. 
The cytoplasmic protein is otherwise termed as transporter protein which is involved in the 
export of substrates such as drugs or antibiotics from the cell, MFP and OMP help in export 
mechanisms. Different classes of RND family efflux pumps have been reported till date in 
Acinetobacter sp. Among these adeABC, adeFGH and adeIJK functions and specificities have 
been studied extensively and overexpression of all these efflux pumps is controlled by two-
component regulatory systems such as sensor and regulator kinase cascade.  
In A. baumannii, AdeABC is one of the common types of efflux pumps which are involved in 
posing resistance to antibiotics such as aminoglycosides, ǃ-lactams, chloramphenicol, 
tetracyclin, trimethoprim, erythromycin and drugs such as ethidium bromide (Magnet et al., 
2001; Peleg et al., 2008). However, many studies seemed to indicate that the presence of 
adeABC and adeDE is species specific, wherein adeABC is being restricted to A. baumannii 
and adeDE to Acinetobacter genomespecies 3 (Chau et al., 2004). Contrastingly, one recent 
study for the first time showed the involvement of AdeABC pump in a non-A. baumannii 
strain and this study also described it in detail and characterized this pump. This 
investigation had also revealed that all three types of RND pumps coexist in non-A. 
baumannii strains (Roca et al., 2011). In AdeABC pump, AdeB is the multidrug transporter 
protein, AdeA is the membrane fusion protein and AdeC is the OMP. The efflux transporter 
AdeB captures the substrates either from within the phospholipid bilayer or the cytoplasm 
and then transports them out via OMP (AdeC). The periplasmic protein AdeA acts as an 
intermediate component which acts as an overpass between AdeB and AdeC components. 
AdeR-S two-component system is likely to control the expression of AdeABC type pumps. 
Further, point mutations in components of AdeABC and its regulatory proteins have been 
associated with overexpression of AdeABC leading to multidrug resistance (Marchand et 
al., 2004).  
One study supports the hypothesis that the increased expression of adeB is associated with 
increased MICs of tigecycline. However, in the absence of an adeB gene knockout 
experiments, it is difficult to ascertain the overall contribution of the AdeABC efflux 
pump to tigecycline nonsusceptibility (Peleg et al., 2007; Hornsey et al., 2010). But, one 
recent study demonstrated that overexpression of the adeABC efflux pump resulted in 
tigecycline nonsusceptibility by quantizing transcripts of the adeB gene and 
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demonstrating conversion of the tigecycline resistance pattern in the presence of an efflux 
pump inhibitor without any previously known mutation (Sun et al., 2010). When the 
isolates were analysed separately, there was an association between a higher MIC and 
elevated adeABC expression, although more isolates would need to be investigated to 
confirm this observation.  
AdeIJK is the second RND type efflux pump reported in A. baumannii, in which adeI, adeJ, 
and adeK genes encode the MFP, transporter and outer membrane components of the pump, 
respectively. This type of pumps are found to be involved in exporting ǃ-lactams, 
chloramphenicol, tetracycline, erythromycin, lincosamides, fluoroquinolones, fusidic acid, 
novobiocin, rifampin, trimethoprim, acridine, safranin, pyronine and sodium dodecyl 
sulphate (Piolle et al., 2008).  
The third RND type efflux pump is AdeFGH, which was found to be functional in the 
mutant in which AdeABC and AdeIJK were non-functional. In one clinically relevant study, 
it was shown that the increased expression of AdeFGH in A. baumannii is an additional 
mechanism for high-level resistance to fluoroquinolones and decreased susceptibility to 
tigecycline. The efficiency of AdeFGH pump is less when compared to the other type of 
efflux pumps because its overexpression was not reported during antibiotic stress and is 
found be constitutively expressed in the cells. AdeL, a LysR type regulator controls the 
expression of AdeFGH operon. The presence of the adeFGH operon in 90% of the strains was 
shown in one study (Coyne et al., 2010). This work also revealed that overexpression of 
adeFGH is likely due to point mutation in adeL, suggesting that this event may possibly 
occur in all clinical strains under selection pressure. More molecular and biochemical 
studies on the transcriptional regulator AdeL should allow better understanding of the 
mechanism of AdeFGH expression in A. baumannii (Coyne et al., 2010) 
2.4.2 MFS type efflux pump 
Major facilitator superfamily (MFS) acts as efflux pumps to decrease the intracellular 
concentrations of multiple toxic substrates and confer multidrug resistance. TetA and TetB 
efflux pumps from the MFS, involved in the tetracycline and minocycline resistance in A. 
baumannii. Many believe that MFS efflux pump is also responsible for the intrinsic 
chloramphenicol resistance described in A. baumannii strains, and therefore it was suggested 
that it can be named CraA, for chloramphenicol resistance Acinetobacter (Magnet et al., 2001; 
Peleg et al., 2008). Recently, a novel efflux pump AmvA (Methyl Viologen resistance) that 
mediates antimicrobial and disinfectant resistance in A. baumannii has been characterized 
(Rajamohan et al., 2010). AmvA is known to be responsible for the transport of toxic 
substances such as acridine orange, acriflavine, benzalkonium chloride, DAPI, deoxycholate, 
ethidium bromide, methyl viologen, SDS and tetraphenylphosphonium chloride(TPPCl). In 
yet another study, two different MFS type efflux pumps such as CmlA and CraA that are 
specific for chloramphenicol resistance have been reported (Roca et al., 2009). 
2.4.3 MATE type efflux pump 
The MATE (Multidrug and Toxic Compound Extrusion) family is the most recently 
categorized, one among the five multidrug efflux transporter families. There are almost 
twenty different types of MATE type transporters reported in bacteria. A proton driven 
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MATE family of efflux pump AbeM is reported in Acinetobacter which was characterized to 
be responsible for exerting resistance to kanamycin, erythromycin, chloramphenicol, 
tetraphenylphosphonium chloride (TPPCl), norfloxacin, ciprofloxacin and trimethoprim (Su 
et al., 2005) 
2.4.4 SMR type efflux pump 
One most recent study for the first time described the role of the SMR efflux pump in 
Acinetobacter spp (Srinivasan et al., 2009). The regulatory protein of this pump AbeS 
mediates resistance to various antibiotics, hydrophobic compounds, detergents, and 
disinfectants in A. baumannii strain AC0037 (Srinivasan et al., 2009). The SMR type pump is 
composed of four transmembrane ǂ-helices of approximately 100–140 amino acids in length 
driven by H+ gradient. A related study concluded that the coupling ion in the AbeM pump 
is H+ and not Na+. It is worthwhile to note that some H + - norfloxacin antiport activity is 
seen earlier in vesicles of E. coli KAM32/pUC18 (Su et al., 2005). 
2.4.5 ABC transporters 
ATP Binding Cassette (ABC) transporters form a special family of membrane proteins, 
characterized by homologous ATP-binding and large, multispanning transmembrane 
domains. Several members of this family are primary active transporters. Whole cell 
proteome analysis of Acinetobacter has revealed the presence ABC transporters which are 
proposed to be responsible for the transport of ferric ion and drug resistance (Iacono et al., 
2008). 
2.5 Aminoglycoside-modifying enzymes (AMEs)  
Resistance to aminoglycosides by AMEs is also a major threatening feature which leads to 
resistant phenotypes which shows resistance to aminoglycoside antibiotics such as 
gentamycin, kanamycin and streptomycin in Acinetobacter spp. All three classes of 
aminoglycoside-modifying enzymes reported have been found in Acinetobacter. These 
enzymes are the O-nucleotidyltransferases (ANT) and O-phosphotransferases (APH) that 
catalyse the nucleotidylation (adenylation) and phosphorylation of the hydroxyl groups and 
finally the N-acetyltransferases (AAC) that catalyse acetylation of amino groups thereby 
rendering the antibiotics inactive. Studies have shown that the genes encoding all these 
enzymes to be present on plasmids, transposons or within integron-type structures.  
In summary, emergence of MDR A. baumannii isolates that are resistant to almost all 
available antibiotics are a serious problem in clinical settings. More ominously, pan drug-
resistant (PDR) and extremely drug-resistant (XDR) A. baumannii isolates that have been 
recently emerged (Park et al., 2009). As a consequence, colistin is now considered as a 
therapy of last resort against MDR Acinetobacter infections (Nation & Li, 2009). 
Unfortunately, colistin resistance has also been reported now (Adams et al., 2009). The 
overexpression of components of PmrAB two-component system such as pmrB and/or 
pmrA appear to be only partially responsible for colistin resistance as shown by Park et al 
(Park et al., 2011). All kinds of mechanisms of antimicrobial resistance in Acinetobacter 
species have been clearly illustrated in Figure – 1.  
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Fig. 1 Potential mechanisms of antimicrobial resistance in Acinetobacter species. General 
depiction of different kinds of antimicrobial resistance mechanisms operating in 
Acinetobacter spp. Five types resistance mechanisms are illustrated in the figure, which is of 
self explanatory 
Finally, more experiments are in need that elucidates the performance of gene knockout 
studies particularly, knockout of the genes for ǃ-lactamases and efflux systems and 
restoration of the genetic support for deficient mechanisms (e.g., porins) will further define 
their roles in Acinetobacter clinical isolates. 
3. Biofilms and antibiotic resistance  
The ability of A. baumannii to adhere to and form biofilms on biotic and abiotic surfaces 
(inanimate objects) may explain its success in the hospital environment. Biofilms might 
contribute to the environmental persistence of Acinetobacter leading to host infection and 
colonization 
3.1 Bacterial biofilms  
The bacterial biofilm have been in nature since very long but, it was not until 1970s that 
science could decipher and appreciate the biofilm lifestyle of bacteria. Biofilm is a complex 
aggregation of microorganisms, wherein the cells are embedded in a self-produced matrix of 
extracellular polymeric substance (EPS). The new definition of a biofilm is a microbially 
derived sessile community characterized by cells that are irreversibly attached to a 
substratum or interface or to each other, are embedded in a matrix of extracellular polymeric 
substances that they have produced, and exhibit an altered phenotype with respect to 
growth rate and gene transcription (Donlan & Costerton, 2002). It is now becoming clear 
that aggregation of bacterial cells are natural assemblages of bacteria within the biofilm 
matrix and it functions as a cooperative consortium, in a relatively complex and coordinated 
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manner. Biofilm phenotype of a pathogen promotes increased colonization and persistence 
and therefore is the leading cause for device-related infections. The ability of these 
pathogens to adhere to human tissues and medical devices and produce biofilms is a major 
virulence factor that correlates with increase in antibiotic resistance, reduced phagocytosis, 
and overall persistence of the bacterial population. Moreover, these biofilms are notoriously 
difficult to eradicate and are a source of many recalcitrant infections. The medical 
importance of the scientific studies of biofilms and its architecture resides more in our 
ability to explain the characteristics of device-related infections and other chronic infections 
and to design strategies to counter their refractory nature. 
3.1.1 Biofilms and resistance  
The mechanisms by which biofilms contribute to reduced susceptibility still remain unclear, 
but a number of different explanations have been proposed. Biofilms are inherently resistant 
to the antimicrobial agents, reasons being failure of an agent to penetrate full depth to cells 
of biofilm or cells slow growing state due to the organism’s slow metabolism. For 
chemically reactive disinfectants such as chlorine, iodine and peroxygens, and for highly 
charged antibiotics, such as the glycopeptides, the glycocalyx does indeed greatly affect the 
ability of the antimicrobial agent to reach those cells that are deep within the biofilm. On the 
other hand, for relatively unreactive, uncharged agents, such as the ǃ-lactams, such reaction-
diffusion limitation is unlikely to occur. The glycocalyx may however, contribute to reduced 
susceptibility to ǃ-lactams, if the antibiotic is susceptible to inactivation by ǃ–lactamases and 
if the ǃ-lactamase is derepressed while the bacterium is in the biofilm mode of growth. In 
such cases, the enzyme is concentrated within the extracellular polymer matrix and 
hydrolyses the drug as it penetrates (Gilbert & Brown, 1998). Reduced susceptibility to ǃ-
lactams amongst biofilm bacteria is more likely to be a function of a diminished growth rate 
within the deeper recesses of the biofilm which causes the expression of penicillin-binding 
proteins that are unrepresentative of those normally targeted by these antibiotics (Gilbert & 
Brown, 1998). Retarded growth also affects the bactericidal action of the ǃ-lactams because 
transpeptidase inhibition, which induces cellular injury, is directly related to growth rate. 
One investigation revealed that gene transfer in biofilms occurs far more frequently than 
previously noticed (Hausner & Wuertz, 1999) and horizontal gene transfer inside a biofilm 
matrix offers a great advantage in terms of both frequency and stability (Hausner & Wuertz, 
1999). The knowledge that attached cells of the same species differ in their ability to 
maintain incoming plasmids hints at specific physiological conditions in biofilms which lead 
to individual cells experiencing different environmental pressures. 
3.1.2 Biofilm cycle – a multistep process  
Attachment to abiotic surface is mainly dependent on cell surface hydrophobicity, whereas 
surface proteins mediate adhesion to host matrix-covered implants. After adhesion to the 
surface, exopolysaccharide, specific proteins and accessory macromolecules aid in 
intercellular aggregation (Otto, 2009). At critical cell density, cells co-ordinate through a 
communication pathway involving signalling molecules, termed quorum sensing (QS), 
resulting in biofilm formation (Costerton et al., 1999). Further, at a later stage, due to 
physical forces or intercellular signalling, the cells detach and disperse to colonize new areas 
(Costerton et al., 1999). 
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3.1.3 Biofilm and disease  
While many biofilm infections are “stealthy,” in that they develop slowly and initially 
produce few symptoms, they may be very damaging because they promote immune 
complex sequelae and act as reservoirs for acute exacerbations in hosts. Many a times host 
immune response products of oxidative bursts rarely penetrate the biofilm matrix 
accounting for the inability of phagocytes to destroy the pathogen (Costerton et al., 1999). 
The exact processes by which biofilm associated organisms elicit disease in the human host 
are poorly understood. However, suggested mechanisms include: (i) detachment of cells or 
cell aggregates from indwelling medical device biofilms, resulting in bloodstream or urinary 
tract infections, (ii) production of endotoxins and (iii) resistance to the host immune system 
(Peleg et al., 2008). One should begin to examine any infection that is refractory to antibiotic 
therapy and to host defences in terms of the genes that are expressed to produce the 
refractory bacterial phenotype. Furthermore, one must begin to use the biofilm phenotype of 
each chronic pathogen in the development of new vaccines and antibiotics aimed at biofilm-
specific targets that can be the means of controlling burgeoning group of diseases caused by 
biofilm phenotype. 
3.2 Biofilm development mechanisms in A. baumannii  
There are three important factors which contribute to the persistence of A. baumannii in the 
hospital environment, namely: resistance to major antimicrobial drugs, resistance to 
desiccation and resistance to disinfectants. This survival property is most likely to play a 
significant role in the outbreaks caused by this pathogen (Tomaras et al., 2003). The potential 
ability of Acinetobacter to form biofilms may explain its outstanding antibiotic resistance 
against a wide range of antibiotics (Rao et al., 2008; Dijkshoorn et al., 2007; Donlan & 
Costerton, 2002). A. baumannii has the ability to colonize both abiotic and medical devices 
(Tomoras et al., 2003) and form biofilms that display decreased susceptibility to multiple 
antibiotics (Uma Karthika et al., 2008). Adherence of A. baumannii to human bronchial 
epithelial cells and erythrocytes has already been demonstrated, with pilus like structures 
appear to be important for adherence (Gospodarek et al., 1998, Lee et al., 2006). This process 
is considered to be a first step in the colonization process of A. baumannii. Survival and 
growth on host skin and mucosal surfaces requires the clones that can resist inhibitory 
agents and the conditions that are exerted by these surfaces. Outgrowth on mucosal surfaces 
and medical devices, such as intravascular catheters and endotracheal tubes can result in A. 
baumannii biofilm formation, which enhances the risk of infection of the bloodstream and 
airways (Tomoras et al., 2003). One of the studies had showed that the common source of 
Acinetobacter bacteremia is intravascular catheters and the colonization of respiratory tract 
(Cisneros et al., 2002). Interestingly, it has also been demonstrated that biofilm formation in 
Acinetobacter is phenotypically associated with exopolysaccharide (EPS) production and 
pilus formation (Tomoras et al., 2004). The protein equivalent to CsuE of Vibrio 
parahaemolyticus, a chaperone has been identified as a key factor in pilus and biofilm 
formation in a pioneer study (Tomoras et al., 2004). Surprisingly, considerable variation in 
quantitative adherence was observed among different strains of A. baumannii isolated from 
the same geographical region (Lee et al., 2006). This observation of varying degree of 
adherence among the strains is in concordance with our studies (unpublished data). Our 
earlier investigation also demonstrated a high propensity among the clinical isolates of A. 
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baumannii to form biofilm and a significant association of biofilms with multiple drug 
resistance (Rao et al., 2008). Thus, biofilm production by A. baumannii promotes increased 
colonization and persistence leading to higher rates of device related infections. 
Identification of new genes involved in biofilm formation is required for better 
understanding of molecular basis of strain variation and various pathogenic mechanisms 
implicated in chronic Acinetobacter infections. 
3.2.1 Factors associated with A. baumannii biofilm formation  
3.2.2 Poly-β-(1, 6)-N-acetlyglucosamine (PNAG) 
One of the important polysaccharides is poly-ǃ-(1, 6)-N-acetlyglucosamine (PNAG), which 
has been now portrayed as a major component of biofilms of bacteria was first described in 
the genus Staphylococci (Maira-Litran et al., 2002). PNAG seems to be having profound 
effects on host-microbe interactions. PNAG affects colonization, virulence, and immune 
evasion in infections caused by both Gram-positive and Gram-negative species (Itoh et al., 
2008). Apart from its role in surface and cell-to-cell adherence (Cramton et al., 1999), PNAG 
is described as an important virulence factor (Kropec et al., 2005) and provides protection 
against the antibiotics and shown to protect Staphylococci against innate host defences (Lewis 
2001 and Voung et al., 2004). Pga locus encodes for the proteins involved in the synthesis 
and translocation of PNAG on to the bacterial surface (Kropec et al., 2005; Shiro et al., 1995; 
Vuong et al., 2004). In S. aureus, PNAG confers resistance to killing mediated by innate host 
immune mediators. Overall, PNAG production by S. aureus appears to be a critical virulence 
factor as assessed in murine models of systemic infection (Kropec et al., 2005). PgaB and 
IcaB (from Staphylococci) contain polysaccharide N-deacetylase domains belonging to 
carbohydrate esterase family 4. PNAG is also shown to be essential for the formation of the 
nonrandom or periodic cellular architecture in E. coli biofilm microstructure and for 
conversion from temporary polar cell surface attachment to permanent lateral attachment 
during the initial stages of biofilm development (Itoh et al., 2008). PgaB of pgaABCD peron 
of E. coli is predicted to be an outer membrane lipoprotein. The hms locus in Yersinia pestis, 
which is equivalent to PNAG operon apparently promotes the transmission of the plague 
bacillus Y. pestis from the flea vector to the mammalian host (Jarrett et al., 2004). PgaB 
ortholog in Y. pestis designated as HmsF, co-purifies with the outer membrane fraction in 
this bacterium.  
PNAG, the most important EPS secreted by the bacterial population also forms the major 
component of the biofilms in Acinetobacter spp. (Choi et al., 2009). Recent study on pgaABCD 
of Gram-negative bacteria with the typical reference strain of A. baumannii showed that the 
four gene loci share a high degree of similarity with E. coli and Y. pestis (Choi et al., 2009). A. 
baumannii pgaA encodes for a predicted 812-amino-acid OMP and it contains a porin domain 
suggesting that it facilitates PNAG translocation across the outer membrane and a 
superhelical periplasmic domain that is thought to play a role in protein-protein interaction 
(Itoh et al., 2008). PgaB is made up of 510 amino acids with a putative polysaccharide 
deacetylase domain. PgaB is an outer membrane lipoprotein that along with PgaA, is 
necessary for PNAG export (Itoh et al., 2008). pgaC encodes for a 392-amino-acid N-
glycosyltransferase that belongs to the glycosyltransferase 2 family. Gene pgaD encodes for a 
150 amino acid protein which localizes in the cytoplasm and assists PgaC in the synthesis of 
PNAG (Itoh et al., 2008). One recent investigation speculated that in a more dynamic 
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environment with higher shear forces, PNAG is more essential for maintaining the integrity 
of A. baumannii biofilms (Choi et al., 2009). 
3.2.3 Biofilm-associated protein (Bap) 
Biofilm-associated proteins (Bap) were first characterized in S. aureus (Cucarella et al 2001) 
and recent research findings indicated that Acinetobacter has a homologue of Bap protein of 
Staphylococcus. Bap family members are high-molecular weight proteins present on the 
bacterial surface, contain a core domain of tandem repeats, and play a critical role in cell-cell 
interactions and biofilm maturation (Loehfelm et al., 2008; Lasa & Penades, 2006). Bap is 
made up of 8620 amino acids, arranged in tandemly repeated modules A-E (Rahbar et al 
2010). It has a higher proportion of negatively charged amino acids in the tandem repeats 
compared to non-tandem repeat parts (Loehfelm et al., 2008). As it has no transmembrane 
anchoring domain, its interaction with the cell wall is unclear and yet to be investigated.  
The mechanism by which the Bap contributes to biofilm development is unknown, though 
their large size and the presence of a high number of repeats suggest that these proteins 
could mediate homophilic or heterophilic intercellular interactions (Lasa & Penades, 2006). 
Structural studies suggest that the main target for Bap is carbohydrates, for maintenance of 
biofilm complex (Rahbar et al., 2010). Time course confocal laser scanning microscopy and 
three-dimensional image analysis of actively growing biofilms demonstrate that Bap mutant 
is unable to sustain biofilm thickness and volume, suggesting a role for Bap in supporting 
the development of the mature biofilm structure. In A. baumannii, Bap is identified as a 
specific cell surface protein and is involved in intercellular adhesion within the mature 
biofilm. Future studies in A. baumannii must explore Bap-mediated interactions like direct 
mediation of intercellular adhesion from one bacterium to a surface receptor on a 
neighboring bacterium, autoadhesion between Bap molecules on adjacent bacteria and/or 
whether cells may be linked indirectly via shared interactions with some extracellular 
biofilm matrix component. However, one can hope that Bap can be a potential target to 
develop a novel vaccine that can abolish biofilm development (Rahbar et al., 2010). 
3.2.4 Chaperone-usher secretion system 
A. baumannii require chaperone-usher pili assembly for the production of biofilm on inanimate 
surfaces as revealed from the study of Tomaras et al (2003). This secretion system encodes for a 
putative pili-like structure/adhesion protein essential for the initiation of biofilm formation. 
The csu operon expressing chaperone-usher pili assembly comprised of a gene cluster that 
encompasses six ORFs: csuAB-A-B-C-D-E and is polycistronic in nature (Tomaras et al., 2003). 
The translational products of the csuD and csuE are highly related to chaperone and usher 
bacterial proteins, respectively, the four remaining ORFs encode hypothetical proteins 
potentially involved in pili assembly (Tomaras et al., 2003). The csu operon is regulated by a 
two-component system, bfmRS. BfmS is a sensor kinase, which senses environmental 
conditions and activates a response regulator encoded by bfmR. Over-expression of the csuAB 
operon is caused by higher BfmR intracellular concentration (Tomaras et al., 2003). Current 
models on biofilm formation clearly implicate the participation of bacterial surface related 
flagella and pili (O’ Toole & Kolter, 1998) and cellular appendages (Tolker-Nielson et al., 2000). 
Bacterial cells in the biofilm community are linked to each other through extracellular 
appendages that resemble pili structures (Tomaras et al., 2003). 
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All the above data suggest that there may be an overlap in factors required for the initiation 
and maturation of biofilms on abiotic and biotic surfaces, bacterial attachment and 
pathogenesis in vivo. Though one can articulate that quorum sensing may be a central 
mechanism for autoinduction of multiple virulence factors such as genes those involved in 
the cell envelope, EPS production, pilus biogenesis, iron uptake and metabolism (Smith, 
2007) and type IV virulence/secretion systems. 
4. Quorum sensing in bacteria 
Many bacteria use cell to cell communication to monitor their population density, 
synchronize their behavior and socially interact. Such communication used by the bacteria is 
chemical in nature and generally designated as quorum sensing (QS) which is nothing but a 
coordinated gene regulation and is generally termed as QS. Small diffusible molecules 
produced by bacteria are ‘signals’ which can reach other cells and elicit ‘answers’. This 
phenomenon relies mainly on cell density and with the increase in cell density, a critical 
concentration of signaling molecule will be reached that allows sensing of the signalling 
molecule and enables the other bacteria to respond. QS is a type of community behaviour 
prevalent among a diverse group of bacteria to switch between planktonic phenotype to 
high cell density biofilm phenotype. Irrespective of either Gram-negative or Gram-positive 
bacteria, the process of QS is analogous in both the groups. The stepwise process involving 
intracellular synthesis of low molecular weight molecules and secrete them to the 
extracellular milieu. When the number of cells in a population increases, the concentration 
of QS molecules also increases and once the minimal threshold level crosses, the molecules 
are recognised by the receptors that trigger signal transduction cascades that result in a 
population wide change in gene expression. Such molecular cascades enable the population 
to function in harmony to survive and proliferate. Depending upon the bacterial species, the 
physiological processes regulated by QS are extremely diverse, ranging from maintaining 
the biofilms to regulating the antibiotic resistance. A flurry of research over the past decade 
has led to significant understanding of many aspects of QS molecules including their 
synthesis, the receptors that recognize the signal and transduce this information to the level 
of gene expression and the interaction of these receptors with the transcriptional machinery. 
Recent studies have begun to integrate QS into global regulatory networks and establish its 
role in developing and maintaining the structure of bacterial communities. 
QS network in Gram-negative bacteria regulate the expression of specific sets of genes in a 
cell density-dependent fashion (Ng & Bassler, 2009). Pathogenic bacteria typically use QS in 
the regulation of genes encoding extracellular virulence factors. Gram-positive bacteria like 
S. aureus secrete small peptides for cell to cell communication. On the other hand Gram-
negatives like A. baumannii predominantly produce small molecules like acylated 
homoserine lactones (Acyl-HSL) as QS entities. Sometimes other signalling molecules such 
as 2-heptyl-3-hydroxy-4-quinolone and diketopiperazines are also produced by Gram-
negative bacteria (Holden et al., 2000) 
4.1 Quorum sensing molecules  
Acyl homoserine lactones (AHLs) are a major class of autoinducer signals used by Gram-
negative proteobacteria for intraspecies communication that are best characterised till date. 
AHLs of QS signalling system seem to control diverse physiological functions such as 
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biofilm formation, Ti plasmid conjugation, production of antibiotics, and competence in 
certain bacteria (Fuqua et al., 2001; Antunes et al., 2010). AHLs are composed of HSL rings 
carrying acyl chains of C4 to C18 in length. These side chains harbour occasional 
modification, notably at the C3 position or unsaturated double bonds. The first AHL 
autoinducer and its cognate regulatory circuit has been first discovered in the 
bioluminescent marine bacterium Vibrio fischeri. Two proteins, LuxI and LuxR, are essential 
for QS control of bioluminescence in V. fischeri. The LuxI/LuxR regulatory system of V. 
fischeri is considered the paradigm for the control of gene expression by QS in Gram-
negative bacteria. Homologs of luxI and luxR have been identified in a large number of 
bacterial genomes and these other LuxIR-type QS systems control global cell density 
dependent gene expression. In V. fischeri, LuxI is the synthase of the QS autoinducer N-3-
(oxo-hexanoyl)-homoserine lactone (3OC6HSL). LuxI catalyzes acylation and lactonization 
reactions between the substrates S-adenosylmethionine (SAM) and hexanoyl-ACP. 
Following synthesis, 3OC6HSL diffuses freely in and out of the cell and its concentration 
increases as the cell density of the population increases (Stevens et al., 1994). LuxR is the 
cytoplasmic receptor for 3OC6HSL as well as the transcriptional activator of the luciferase 
operon. Without the 3OC6HSL ligand, the LuxR protein is unstable and is rapidly 
degraded. When 3OC6HSL accumulates, it is bound by LuxR and the LuxR-AHL complex 
recognizes a consensus binding sequence (lux box) upstream of the luciferase operon and 
activates its expression. Because expression of luxI is also activated by 3OC6HSL-bound 
LuxR, when the QS circuit engages, autoinducer production is induced, and the 
surrounding environment is flooded with the signal molecule. This autoinduction positive 
feedback loop is presumed to enforce synchrony as the population of cells switches from 
low cell density mode to high cell density QS mode (Stevens et al., 1994; Schaefer et al., 
1996). 
The QS networks are increasingly gaining importance in clinical isolates as they function as 
global regulators. One of the well studied organisms in clinical context is P. aeruginosa, 
which uses AHL as a QS signaling molecule. In P. aeruginosa, the QS network is found to 
play a major role in maintaining biofilm, this biofilm matrix in turn helps the bacteria to 
survive hostile conditions by becoming resistance to bactericidal agents, resisting nutrition 
depleted conditions and thereby helps them to remain persistent in hospital environment 
that makes complete eradication of this organism a challenging quest. 
4.2 Quorum sensing in A. baumannii  
Quorum sensing (QS) in A. baumannii appears to have a regulatory role in biofilm formation 
(Smith et al., 2007). Environmental survival and growth require attributes such as resistance 
to desiccation and antibiotics, versatility in growth requirements, biofilm forming capacity 
and possibly, QS activity (Dijkshoorn et al., 2007; Smith, 2007). QS has been shown to 
regulate a wide array of virulence mechanisms in many Gram-negative organisms (Antunes 
et al., 2010) and Acinetobacter is no different. The presence of QS has been inferred from the 
detection of a gene that is involved in autoinducer production (Gaddy et al., 2009) that could 
control the various metabolic processes, production of virulence factors, including biofilm 
formation. QS network in Acinetobacter is mediated by acyl homoserine lactones (AHL). Up 
to five different QS signal molecules that are more detectable (produced abundantly) during 
the stationary phase have been identified in Acinetobacter, indicating that this may be a 
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central mechanism for autoinduction of multiple virulence factors (Gonzalez et al., 
2001;Joly-Guillou et al., 2005; Niu et al., 2008; Gonzalez et al., 2009). In one most recent 
study, different species of Acinetobacter were analyzed for the production of AHL and it was 
shown that QS sensors were not homogenously distributed among species, though one 
particular AHL was specifically present in most of the strains belonging to A. calcoaceticus-A. 
baumannii complex (Gonzalez et al., 2009). Furthermore, it was revealed that no distinction 
could be made between the QS signals secreted by typical opportunistic strains of the A. 
calcoaceticus-A. baumannii complex isolated from patients and strains belonging to other 
species of the genus (Gonzalez et al., 2009). In our investigation, we have also identified 
more than six different QS signal molecules in majority of the A. baumannii clinical isolates 
wherein chromatographic separation (Thin Layer Chromatography) of ethyl acetate 
extracts followed by ǃ-galactosidase assay for determining QS activity using A. 
tumefaciens reporter strain NT1, containing plasmid pZLR4 carrying traR and a traG::lacZ 
reporter fusion was used. However, among these only one kind of QS molecule was 
produced abundantly (Figure – 2). 
 
A:- Biosensor overlay test using reporter strain (Agrobacterium tumefaciens pZLR4) for detection of 
quorum sensing (QS) molecules; 1A – Negative control; 2A A. tumefaciens Positive control 
NTL4(pTiC58∆accR); 3A - QS activity positive reaction produced ethyl acetate extract of A. baumannii 
clinical isolate confirming the production Acyl Homoserine lactone 
B:- 1B- Biofilm production in A. baumannii isolates detected through Tube method using 1% crystal 
violet stain. Thick violet ring was witnessed between liquid air interfaces; 2B - Thin layer 
chromatography (TLC) of crude ethyl acetate extract of A. baumannii culture supernatant; 3B - Ethyl 
acetate extracts obtained from A. baumannii culture supernatants were separated by TLC and over laid 
with A. tumefaciens (pZLR4). 
Fig. 2. Quorum sensing activity in A. baumannii  
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Another recent investigation on A. baumannii M2 strain characterized an AHL and one AHL 
synthase gene was identified, which was held responsible for predominant of kind QS 
molecule produced (Niu et al., 2008). Although additional AHLs were detected in this 
study, they were not able detect any other gene related to them. Hence, it appears that the 
auto inducer synthase that was discovered has low specificity and may be capable of 
synthesizing other QS signals as well. Some interesting questions arising out of above study 
are: do the diversity of QS signals observed respond only to particular synthase? or is there 
any existence of more than one AHL synthase?  
However, since AHL signals produced by acyltransferases do not have similarity to LuxI or 
LuxM/AinS, it cannot be ruled out that additional AHL signals are present in A. baumannii 
M2. The AbaI protein was similar to members of the LuxI family of autoinducer synthases 
and was predicted to be the only autoinducer synthase encoded by A. baumannii. The 
expression of abaI at the transcriptional level was activated by ethyl acetate extracts of A. 
baumannii culture supernatants or by synthetic 3-hydroxy-C12-HSL. Further an abaI mutant 
failed to produce any detectable AHL signals and was impaired in biofilm development 
indicting that there is direct role QS molecules in biofilm development (Niu et al., 2008). QS 
machinery in A. baumannii appear to be mediated by a two component system AbaIR (Niu et 
al., 2008). This two-component system is homologous to a typical LuxIR family of proteins 
found in Gram- negative bacteria. This system includes a sensor protein AbaI that functions 
as an enzyme synthesizing AHLs and AbaR that functions as receptor by recognizing the 
AHL and induces a cascade of signaling pathway(s). QS was found to play a major role in 
biofilm maintenance and maturation in Acinetobacter. Niu et al (2008) have revealed that in 
abaI null mutants, there is about 40% reduction of biofilm and this was restored when AHL 
supplied externally. Consistent with this study, scanning electron microscopy (SEM) 
analysis data from our laboratory has shown biofilm formation in biofilm-negative clinical 
isolates when AHL was provided exogenously, as well there was enhanced biofilm 
formation in weakly adherent clinical isolates after such supplementation (Figure– 3). A. 
baumannii was found to produce more than 5 types of AHLs with varying fatty acid chains 
(Gonzalez et al., 2001 & 2009; Niu et al., 2008). The abaI autoinducer synthase was found to 
produce N-(3-hydroxydodecanoyl)-L-HSL (3-hydroxy-C12-HSL) when cloned and 
expressed in E. coli. Genomic sequence analysis of A. baumannii ATCC 17978 has revealed 
that abaI and acyltransferase may be the core mediator for synthesis of AHLs with varying 
chemical nature. Such observations as whole underpin a positive correlation between QS 
and biofilm formation 
A comparative study using in silico tools have shown that the autoinducer synthase gene 
abaI is more than 45% identical to autoinducer synthase gene from environmental non-
pathogenic organisms like Halothiobacillus neapolitanus, Acidithiobacillus ferrooxidans 
ATCC23270 and less identical to RhlI and LasI system of pathogenic P. aeruginosa but about 
47.3% identical to autoinducer synthase genes of an environmental strain Pseudomonas sp 
RW10S (Bhargava et al., 2010). These similarities and dissimilarities between environmental 
and clinical isolates clearly demonstrates how Acinetobacter as evolved from an 
environmental form to a pathogenic individual. Further, in-depth analysis has revealed that 
A. baumannii has more similarity with Burkholderia ambifaria at organism level and in stark 
contrast, its abaI gene shares similarity with H. neapolitanus. Similarly, abaR was found to 
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share more similarity to H. neapolitanus but it is unrelated to B. ambifaria. This can raise 
another question that abaI and abaR are two different genes yet they share similarity with 
homologs of another organism and it is because abaR is present just 63 base pairs upstream 
of abaI and it can be easily transferred as a single unit from one organism to the other. 
 
1A- Growth of A. baumannii (biofilm-negative) on glass cover slip stained with 0.1% of crystal violet; 
2A- Effect of N-AHL (200µM) extracted from A. baumannii biofilm phenotype on growth of biofilm non-
producer; biofilm development can be observed. 3A - Effect of garlic extract on growth and biofilm 
formation; inhibition of biofilm was observed. 
1B & 2B - SEM images of preparations similar to 1A & 2A respectively (X 5000 magnification); 3B 
magnified images showing cell to cell adherence through pili-like appendages (X 15000 magnifiction). 
Fig. 3. A & B – Microscopic and scanning electron microscopic (SEM) analysis of effect of N-
Acyl homoserine lactone (AHL) and garlic extract (Quorum quenching agent) on biofilm-
negative strains of A. baumannii of clinical origin.  
The likely lateral gene transfer between two distinct bacteria can be attributed to the natural 
competence of A. baumannii that has made them to acquire genetic information from other 
organisms. Interestingly, QS sensing is well known to increase competence in bacteria which 
further illuminates the importance of these chemical mediators. 
A. baumannii being found to be a major threat in many hospitals, recent studies have clearly 
demonstrated the alarming need for an intense research on QS in A. baumannii. Pandrug 
resistance of A. baumannii is attributed to a number of antibiotic resistance mechanisms and 
biofilm formation. This biofilm formation is in turn regulated by QS networks, which make 
them to be considered as an important drug target to combat these multidrug resistant 
superbugs. 
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4.3 Quorum sensing and Antibiotic resistance  
Multiple drug resistance can be attributed to a number of mechanisms, which includes 
synthesis of enzymes that degrade the drugs, modified targets that does not respond to the 
drug and presence of efflux pumps that pumps out the bactericidal drugs from the bacterial 
system to the extracellular milieu. QS was found to be regulating multidrug resistance in 
two ways, one involves up regulation of biofilm associated EPS matrix and other by up 
regulation of efflux pump genes.  
The production of an EPS matrix is one of the distinguishing characteristics of biofilm and it 
has been suggested that EPS prevents the access of antibiotics into the bacterial community. 
Our investigations reveal that there is a strong association between multidrug resistance and 
biofilms wherein majority of our clinical isolates, which were strong biofilm producers were 
also exhibiting multidrug resistance (Rao et al., 2008). Compared to non-biofilm producers, 
biofilm producers showed a significantly higher resistance to cephotaxime, amikacin, 
ciprofloxacin and aztreonam. Thus, it is clear that clinical isolates of A. baumannii have a 
high propensity to form biofilm and there is a significant association of biofilms with 
multiple drug resistance. Further investigation showed that presence of antibiotic resistant 
determinant blaPER-1 is more critical for cell adherence, which is the first step in biofilm 
formation cycle. One of the success stories of Acinetobacter is its ability to withstand stress 
conditions like exposure to high dose of antibiotics. Previous studies on Pseudomonas have 
shown that exposure to the macrolide antibiotics found to enhance biofilm formation. Such 
responses suggest biofilm as a potential defence mechanism against antibiotics. Similar 
mechanism is seen in A. baumannii in which strong biofilm producers are commonly 
multidrug resistant. The role of QS molecule as a key player in antibiotic resistance can be 
understood from their mechanism of enhancing replication and transfer of plasmids, which 
are the major carriers of antibiotic resistant genes. Thus in a biofilm microstructure there is an 
increased possibility of gene transfer including genes for antibiotic resistance. Consequently, 
the biofilm forming capacity of A. baumannii combined with its multidrug resistance 
contributes to the organism’s survival and further dissemination in the hospital settings. 
Evidences for the role of QS in upregulating efflux pumps arise from studies in E. coli in 
which over expression of E. coli luxR homologue SdiA lead to the overexpression of AcrAB 
efflux pumps and its knockout lead to decrease in AcrAB efflux gene expression. This study 
clearly demonstrates how QS directly play an indispensable role in regulating efflux pump 
gene expression. SdiA as well regulates cell division in a cell density-dependent manner. It 
was also shown that SdiA controls multidrug resistance by positively regulating the MDR 
pump AcrAB and overproduction of SdiA confers multidrug resistance and increased levels 
of AcrAB. Conversely, sdiA null mutants are hypersensitive to drugs and have decreased 
levels of AcrB protein. These observations provide a direct link between QS and MDR 
achieved through efflux pump. Combined with earlier reports, this data support a model in 
which a role of drug efflux pumps is to mediate cell–cell communication in response to cell 
density (Rahmati et al., 2002). Now, it is clear that sdiA positively regulates the AcrAB efflux 
pump to mediate multiple drug resistance in E. coli. 
In P. aeruginosa, when the cells are in the logarithmic growth phase, the MexR repressor 
negatively regulates mexAB-oprM efflux pump expression by binding at the MexR-MexAB-
OprM operator-promoter region. As the cells enter the stationary growth phase, they sense a 
high population density and turn on a QS switch producing an autoinducer, C4-HSL, which 
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independently induces the expression of mexAB-oprM operon directly or it inactivates the 
MexR repressor, as a consequence it enhances the transcription of MexAB–OprM efflux 
pump (Maseda et al., 2004). This study also revealed that MexAB mutants accumulate 3O-
C12-HSL intracellularly, which shows how QS signals form a part of efflux pump networks. 
In A. baumannii, antibiotic resistance is also brought about by a number efflux pump genes 
and the RND efflux genes which are found to share about 47% similarity with MexAB 
pumps are the major efflux pumps in A. baumannii. A. baumannii also produces C12-HSL 
compounds as QS molecules, which shows that there may be an interconnecting role 
between efflux pumps and QS that imparts multiple drug resistance. 
To overcome stress, cells express various factors and one of them is RpoS which is regulated 
by the global regulator Hfq. In one of the studies conducted in P. aeruginosa, lasR knockout 
mutants showed decreased resistance to ofloxacin, whereas the resistance was restored 
when RpoS was over expressed in lasR knockouts. This finding suggests the strong role of 
stress regulators in multiple-drug resistance. As Hfq was found to regulate RpoS which in 
turn involved in orchestrating QS controlling antibiotic resistance, one can understand the 
pivotal role of stress regulators in QS and multidrug resistance. Acinetobacter genome 
analyses provide evidences for the presence of both Hfq and RpoS in A. baumannii though 
their interconnecting role is not yet elucidated. 
4.4 Biofilm associated gene expression and virulence factors  
Many recent investigations have revealed differential gene expression of genes during 
biofilm formation. Since biofilm helps in persistence of the organism in various stressful 
environments including survival in human hosts, many stress tolerating factors (can also 
termed as virulence factors) are produced to overcome a range of stress conditions. In this 
regard, our investigations have shown a positive correlation between biofilm and virulence 
factors. Our study which included majority of clinical isolates of A. baumannii that are 
biofilm producers were also found to be positive for production of virulence factors like 
protease, gelatinase, phospholipase, serum resistance and haemolysis (unpublished data). 
These factors are highly helpful for the pathogens survival in human hosts. Thus our 
observation sturdily supports a positive correlation between biofilm and virulence factors. 
Some cells in biofilm have slow growth rate, which is related to general stress response 
rather than nutrient limitations. To overcome stress, cells express various factors and one of 
them is RpoS which is regulated by the global regulator Hfq. As Hfq was found to regulate 
RpoS which in turn leads to QS controlled expression of virulence factors, one can 
understand the pivotal role of Hfq during harsh conditions. A general model of QS network 
with overall role of AHL in signal transduction regulated by AbaR, possible role of AbaI, 
Hfq, RpoS in Acinetobacter spp. is depicted in Figure – 4. 
In conclusion, QS sensing works as a global regulator in regulating a diversified network of 
signalling cascades which helps the organism to resist infinite hostile conditions that are yet 
to be unveiled. Bacterial virulence being shown as one of the functions regulated by QS may 
therefore be a right target for designing newer therapeutics. Consequently, interference with 
QS-based inter-cellular communication might become the basis of new therapeutic schemes. 
Moreover, understanding QS cascades apart from revealing the communal relationships 
between the cells may help in designing potential drugs which can tackle multidrug 
resistant superbug A. baumannii. 
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Fig. 4. A General model of acyl-homoserine lactone (AHL) signal transduction in 
Acinetobacter spp. by quorum sensing is shown. Tentative model for AHL synthesis (left side) 
and AHL interaction with AbaR-type regulatory proteins (right side) are depicted. Green 
solid arrows on the outer membrane indicate the potential two-way traffic of AHLs into and 
out of the cell. Putative regulatory role of AbaR and its interaction with AbaI or AbaI-type 
protein is shown at left side. Putative activation and overexpression of AdeABC efflux 
pump by AHL- AbaR complex is depicted by green dotted arrows at the right side. The 
presumed role of AHL- AbaR complex in up regulation of Hfq expression and putative 
regulation of RpoS by Hfq are shown. Finally, role of RpoS in antibiotic resistance and its 
probable role in biofilm development are illustrated.  
5. Future prospective  
Ironically, many have started believing that we are nearing the post antibiotic era as no new 
groups of antibiotics have been discovered after 1980s. As such, we are in a desperate need 
for searching new therapeutic solutions for infections caused pan-drug resistant bacteria. 
We might achieve this with respect to nosocomial pathogen A. baumannii after some careful 
studies of the genomics and proteome of Acinetobacter species looking for possible 
promising targets. In the following paragraphs, we describe one of the potential targets as 
an example, where we have tried to relate iron metabolism to biofilm production, which is 
based entirely on indirect evidences but strong correlation of A. baumannii with its other 
close relatives in a genomic perspective. 
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The remarkable similarities between the prokaryote and eukaryote iron transport systems 
underscore the importance of our analysis with respect to the host-bacteria interactions 
leading to disease. An increased knowledge of the molecular mechanisms of microbial 
pathogenicity mediated by iron and host resistance will undoubtedly help in finding 
potential drug targets. The iron-scarce environment of a vertebrate host generates a non-
specific defence mechanism as most iron is bound with host proteins such as haemoglobin, 
or complexed with high affinity ligands such as transferrin and lactoferrin (Neilands et al., 
1995). To overcome this, A. baumannii and other Gram-negatives secrete high affinity iron 
chelators, called siderophores that gather this micro- but essential nutrient (Neilands et al., 
1995; Crosa, 1989). Siderophores (from the Greek: “iron carriers”) are defined as relatively 
low molecular weight, ferric ion specific chelating agents elaborated by bacteria and fungi 
growing under low iron stress environment. The role of these compounds is to scavenge 
iron from the environment and to make the mineral and make it available to the cell. The 
ability to extract iron from these iron-scarce environments of the host often contributes to 
the virulence of a successful pathogen. 
5.1 Iron metabolism in Y. pestis and A. baumannii 
Indeed, there have been reports that iron deficient media suppress biofilm formation and 
hence decrease virulence (Weinberg, 2004; Yang et al., 2007). But, this would do nothing to 
hinder the growth of the pathogen as the siderophores perform superbly, the task of iron 
acquisition with their extremely high affinity for ferric ion (Neilands et al., 1995; Braun and 
Hantke, 2011). We certainly have a choice of targeting the iron acquisition system so as to 
abolish the virulence. Recent studies on human Gram-negative pathogen Y. pestis suggest 
that the HmsHFRS and HmsT operons regulating hemin-binding and storing system are 
also involved in biofilm formation (Perry et al., 1990; Kirillina et al., 2004). In fact, Y. pestis 
Hms+ phenotype, described by enormous adsorption of hemin or congo red to become red 
coloured, is a manifestation of biofilm formation during growth at 26–34 ºC (Perry et al., 
2004). A. baumannii has genes homologous to HmsH, HmsF and HmsR that occur end-to-
end and (may) constitute an operon having a pair of hypothetical genes and spanning about 
a 4.7 kb region along the complementary strand of the genome (Figure-5). 
 
Fig. 5. A comparison between (A) Y. pestis Hms operon and (B) a 4.7 kb region of A. 
baumannii genome (see text) having four genes. Matching colours except dark grey colour 
showing homologues. Dark grey segments do not match. Promotor and intergenic 
sequences are ignored for the sake of simplicity. 
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Y. pestis HmsH is an outer membrane protein with a predicted ǃ-barrel domain (Wortham et 
al., 2010) and has a weak homology to A. baumannii poly-beta-1, 6-N-acetyl-D-glucosamine 
(PGA) synthesis protein. HmsF is also an outer membrane protein with a predicted 
deacetylase domain. HmsR and HmsS are inner membrane proteins (Wortham et al., 2010). 
HmsR has a putative glycosyl-transferase domain where as HmsS homologue Ica is linked 
to the Y. pestis biofilm PGA synthesis protein PgaD. Y. pestis HmsH, HmsF, HmsR and 
HmsS have 58.2%, 60.8%, 83% and 50% sequence similarities to E. coli PgaA, PgaB, PgaC, 
PgaD respectively (Forman et al., 2006). But, they have very weak similarities with their 
(predicted) A. baumannii counterparts. Yet, from some recent investigations, it is now 
becoming obvious that genes from Hms operon have corresponding counterparts in A. 
baumannii (Zhou and Yang, 2001). 
The above mentioned 4.7 kb region in genome of A. baumannii contains 4 genes in tandem, 
which consists of a pair of hypothetical proteins, bearing IDs YP_001085192 and 
YP_001085192 followed by a putative hemin storage signal peptide protein and hemin 
storage system protein HmsR. Neither the sequence nor the structural topology of 
YP_001085192 fits into any of the genes of Y. pestis HmsHFRS operon. Rather, according to 
UniProtKB annotations, it is a putative phosphotransferase, containing a nucleotide 
(possibly ATP) binding motif. There have been some evidences of phosphoenolpyruvate 
phosphotransferase (PTS) systems being involved in biofilm formation in Vibrio cholerae, E. 
coli and Streptococcus gordonii (Houot and Watnick, 2008; Lazazzera, 2010; Houot et al., 2010). 
YP_001085191, when searched against RefSeq (Pruitt et al., 2000) database, comes to be A. 
baumannii poly-beta-1, 6 N-acetyl-D-glucosamine export porin PgaA, which could be 
involved in the export of PGA to the cell exterior. The putative hemin storage signal peptide 
gene, as the name suggests, is involved in hemin storage. Searching results in the Conserved 
Domain Database (CDD) (Marchler- Bauer et al., 2011) suggested further that it has one each 
of polysaccharide deacetylase and poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase 
PgaB domains. The polysaccharide deacetylase domain is found in polysaccharide 
deacetylase. This family of polysaccharide deacetylases includes NodB (nodulation protein 
B from Rhizobium), which is a chito-oligosaccharide deacetylase. It also includes chitin 
deacetylase from yeast and endoxylanases which hydrolyses glucosidic bonds in xylan 
(Fukushima et al., 2004). Poly-beta-1, 6-N-acetyl-D-glucosamine N-deacetylase PgaB 
produces polysaccharides based on N-acetyl-D-glucosamine in straight chains with beta-1, 6 
linkages. Deacetylation by this protein appears necessary to allow export through the porin 
PgaA (Itoh et al., 2008). The last one in the order, HmsR, as resulted in the CDD search, 
belongs to the cellulose synthase superfamily (Roberts and Bushoven, 2007) and also 
contains a DXD motif which binds to a metal ion that is used to coordinate the phosphates a 
nucleotide-sugar at the active site. These features suggest that A. baumannii, like its near 
relatives, depends on hemin-adsorption and storage for biofilm formation. 
Neither the hemin acquisition (Zimbler et al., 2009) nor the biofilm function has remained 
uncharacterized in A. baumannii. But the above discussion correlates these two and suggests 
that they are not independent of each other. Even A. baumannii is able to survive without the 
help of iron chelators, if its Hms system is functional (Zimbler et al., 2009). On the contrary, 
an Hms negative almost does not develop biofilms (Figure-6) (Jarrett et al., 2004). One 
previous work (James et al., 2006) had revealed that genes coding for hemin and iron 
acquisition systems in Porphyromonas gingivalis are regulated by QS protein LuxS. Again QS 
is well known for inducing biofilm formation. 
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Fig. 6. Scanning electron microscopy of Hms-positive (A) and Hms-negative (B) Yersinia 
pestis grown on agar plates at 21˚C. Bar, 0.5 µm. Reproduced with the permission from Jarret 
et al., 2004.  
6. Conclusion  
This review attempted to give a glimpses of multiple mechanisms of antimicrobial resistance 
adopted by various species of Acinetobacter, described the current understanding of biofilm 
development and various factors regulating the biofilm formation in Acinetobacter. This 
write up also explained about the biofilm development and different virulence factors 
elaborated by Acinetobacter and its correlation with antibiotic resistance. Finally, quorum 
sensing has been elucidated in detail, which works as a global regulator in controlling and 
regulating diverse physiological functions such as biofilm formation, pilus biogenesis, 
production of multiple virulence factors, development of antibiotic resistance and increasing 
the competence of cells that helps in gene transfer. All the information discussed here will 
definitely help the future research in this area. 
In conclusion, all the available evidence implies that A. baumannii is very important human 
pathogen that is gradually gaining more attention as a major global public health problem. 
It is responsible for a significant proportion of nosocomial infections among patients who 
are critically-ill receiving intensive care in the ICUs. With this situation together with the 
fact that certain biofilm phenotypes of A. baumannii being highly refractile and recalcitrant 
that are highly resistant to multiple drugs due to intrinsic resistance properties and those 
that can acquire resistant determinants with increasing propensity, makes this pathogen one 
of the most difficult challenges of the present days.  
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